Genvax is a startup animal vaccine company located in Ames, Iowa. We have a dynamic team of experienced scientists and entrepreneurs poised to develop next generation mRNA + nanoparticle vaccines. This isn’t the first go-around for co-founders Joel Harris and Dr. Hank Harris, who successfully created, grew and sold Harrisvaccines to Merck Animal Health in 2015.
Our Mission: Genvax Technologies accelerates breakthrough solutions to the animal health industry. We commercialize the tools for livestock producers and veterinarians that no one else can.
Our Vision: We believe in rapidly responding to the world around us. We cultivate new ideas to develop novel solutions and create a long-lasting impact on animal health world-wide.
Our Mission: Genvax Technologies accelerates breakthrough solutions to the animal health industry. We commercialize the tools for livestock producers and veterinarians that no one else can.
Our Vision: We believe in rapidly responding to the world around us. We cultivate new ideas to develop novel solutions and create a long-lasting impact on animal health world-wide.
Location: United States, Iowa, Ames
Employees: 1-10
Total raised: $6.5M
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | Ag Venture... | agventures... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.08.2022 | Seed | $6.5M | - |
Mentions in press and media 2
| Date | Title | Description |
| 04.02.2025 | Genvax Technologies Closes Series Seed Plus Round | Genvax Technologies, an Ames, IA-based startup dedicated to bringing advances in RNA vaccine production to animal health, raised an undisclosed amount in Series Seed Plus funding. The round was led by United Animal Health. The company inten... |
| - | Genvax Technologies | “Home” |